Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CHE NYSE:DGX NYSE:DVA NYSE:LH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEChemed$440.10+2.1%$448.87$408.42▼$623.60$6.42B0.43192,198 shs147,258 shsDGXQuest Diagnostics$189.71+1.5%$182.44$146.91▼$191.49$21.19B0.56914,530 shs983,924 shsDVADaVita$125.79+0.4%$132.49$122.93▼$179.60$9.00B1.13771,447 shs391,323 shsLHLabcorp$285.66+0.7%$277.19$209.38▼$289.20$23.76B0.89552,162 shs453,346 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEChemed0.00%+2.51%-3.99%-2.40%-27.53%DGXQuest Diagnostics0.00%+2.95%+3.31%+13.74%+27.41%DVADaVita0.00%+1.52%-3.44%-10.87%-23.66%LHLabcorp0.00%+2.77%+3.05%+17.20%+31.75%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEChemed$440.10+2.1%$448.87$408.42▼$623.60$6.42B0.43192,198 shs147,258 shsDGXQuest Diagnostics$189.71+1.5%$182.44$146.91▼$191.49$21.19B0.56914,530 shs983,924 shsDVADaVita$125.79+0.4%$132.49$122.93▼$179.60$9.00B1.13771,447 shs391,323 shsLHLabcorp$285.66+0.7%$277.19$209.38▼$289.20$23.76B0.89552,162 shs453,346 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEChemed0.00%+2.51%-3.99%-2.40%-27.53%DGXQuest Diagnostics0.00%+2.95%+3.31%+13.74%+27.41%DVADaVita0.00%+1.52%-3.44%-10.87%-23.66%LHLabcorp0.00%+2.77%+3.05%+17.20%+31.75%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHEChemed 2.80Moderate Buy$578.5031.45% UpsideDGXQuest Diagnostics 2.53Moderate Buy$189.06-0.34% DownsideDVADaVita 1.80Reduce$153.2521.83% UpsideLHLabcorp 2.73Moderate Buy$296.463.78% UpsideCurrent Analyst Ratings BreakdownLatest CHE, DGX, LH, and DVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/17/2025DGXQuest DiagnosticsUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$180.00 ➝ $190.0010/17/2025DGXQuest DiagnosticsMizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$190.00 ➝ $210.0010/17/2025LHLabcorpMizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$285.00 ➝ $320.0010/17/2025LHLabcorpUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$305.00 ➝ $325.0010/14/2025LHLabcorpTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$320.0010/14/2025DVADaVitaTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$140.0010/14/2025DGXQuest DiagnosticsTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$195.0010/9/2025DVADaVitaBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$160.00 ➝ $149.0010/8/2025CHEChemedWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)10/8/2025DGXQuest DiagnosticsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B)10/8/2025DGXQuest DiagnosticsEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetIn-Line$185.00 ➝ $190.00(Data available from 10/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHEChemed$2.43B2.64$25.69 per share17.13$74.35 per share5.92DGXQuest Diagnostics$9.87B2.15$13.52 per share14.03$61.38 per share3.09DVADaVita$12.82B0.70$19.12 per share6.58$4.83 per share26.04LHLabcorp$13.01B1.82$22.39 per share12.76$96.27 per share2.97Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHEChemed$302M$19.4522.6318.892.5611.56%25.83%17.77%10/28/2025 (Confirmed)DGXQuest Diagnostics$871M$8.3522.7218.082.519.01%15.24%6.64%10/21/2025 (Estimated)DVADaVita$936.34M$10.1712.379.900.906.35%369.39%4.62%10/29/2025 (Estimated)LHLabcorp$746M$9.0631.5316.291.835.66%15.45%7.02%10/28/2025 (Estimated)Latest CHE, DGX, LH, and DVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/29/2025Q3 2025DVADaVita$3.29N/AN/AN/A$3.43 billionN/A10/28/2025Q3 2025CHEChemed$5.39N/AN/AN/A$626.04 millionN/A10/28/2025Q3 2025LHLabcorp$4.12N/AN/AN/A$3.56 billionN/A10/21/2025Q3 2025DGXQuest Diagnostics$2.51N/AN/AN/A$2.73 billionN/A8/5/2025Q2 2025DVADaVita$2.70$2.95+$0.25$2.58$3.36 billion$3.38 billion7/29/2025Q2 2025CHEChemed$6.02$4.27-$1.75$3.57$650.60 million$618.80 million7/24/2025Q2 2025LHLabcorp$4.14$4.35+$0.21$2.84$3.49 billion$3.53 billion7/22/2025Q2 2025DGXQuest Diagnostics$2.57$2.62+$0.05$2.47$2.73 billion$2.76 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHEChemed$2.400.55%N/A12.34%16 YearsDGXQuest Diagnostics$3.201.69%N/A38.32%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHLabcorp$2.881.01%N/A31.79%N/ALatest CHE, DGX, LH, and DVA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date10/8/2025LHLabcorpquarterly$0.721.04%11/26/202511/26/202512/11/20258/13/2025DGXQuest Diagnosticsquarterly$0.801.79%10/3/202510/3/202510/20/20258/1/2025CHEChemedquarterly$0.600.6%8/11/20258/11/20258/29/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHEChemedN/A1.861.83DGXQuest Diagnostics0.711.090.99DVADaVitaN/A1.391.34LHLabcorp0.611.501.32Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHEChemed95.85%DGXQuest Diagnostics88.06%DVADaVita90.12%LHLabcorp95.94%Insider OwnershipCompanyInsider OwnershipCHEChemed3.29%DGXQuest Diagnostics8.16%DVADaVita1.50%LHLabcorp0.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHEChemed15,69514.57 million14.09 millionOptionableDGXQuest Diagnostics56,000111.82 million102.70 millionOptionableDVADaVita76,00071.50 million70.43 millionOptionableLHLabcorp70,00083.10 million82.40 millionOptionableLH, DGX, DVA, and CHE HeadlinesRecent News About These CompaniesLabcorp (NYSE:LH) & CVS Health (NYSE:CVS) Critical Contrast4 hours ago | americanbankingnews.comUBS Maintains Labcorp Holdings (LH) Buy RecommendationOctober 18 at 1:18 PM | msn.comUBS Group Raises Labcorp (NYSE:LH) Price Target to $325.00October 18 at 10:11 AM | marketbeat.comAngeles Wealth Management LLC Makes New Investment in Labcorp Holdings Inc. $LHOctober 18 at 5:15 AM | marketbeat.comLabcorp Holdings Inc. $LH Shares Acquired by Allianz Asset Management GmbHOctober 18 at 4:55 AM | marketbeat.comLabcorp price target raised to $320 from $285 at MizuhoOctober 17 at 7:48 PM | msn.comNordea Investment Management AB Grows Holdings in Labcorp Holdings Inc. $LHOctober 17 at 5:54 AM | marketbeat.comGenerali Asset Management SPA SGR Trims Stake in Labcorp Holdings Inc. $LHOctober 16 at 5:30 AM | marketbeat.comLabcorp Holdings Inc. $LH Shares Sold by Boston Trust Walden CorpOctober 16 at 5:00 AM | marketbeat.comCallan Family Office LLC Takes Position in Labcorp Holdings Inc. $LHOctober 16 at 3:34 AM | marketbeat.comLabcorp Holdings Inc. (NYSE:LH) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesOctober 16 at 2:41 AM | americanbankingnews.comLabcorp Holdings Inc. (NYSE:LH) Receives Average Rating of "Moderate Buy" from BrokeragesOctober 16 at 2:39 AM | marketbeat.comIf You Invested $100 In Labcorp Hldgs Stock 20 Years Ago, You Would Have This Much TodayOctober 15, 2025 | benzinga.comLabcorp Gears Up to Report Q3 Earnings: What's in Store for the Stock?October 15, 2025 | zacks.comWilmington Savings Fund Society FSB Trims Holdings in Labcorp Holdings Inc. $LHOctober 15, 2025 | marketbeat.comLabcorp Holdings Inc. $LH Shares Bought by Vanguard Personalized Indexing Management LLCOctober 15, 2025 | marketbeat.comLabcorp price target raised to $320 from $310 at TruistOctober 15, 2025 | msn.comWhy Labcorp Holdings (LH) is a Top Momentum Stock for the Long-TermOctober 14, 2025 | zacks.comEquitable Trust Co. Boosts Position in Labcorp Holdings Inc. $LHOctober 14, 2025 | marketbeat.comAberdeen Group plc Purchases 3,599 Shares of Labcorp Holdings Inc. $LHOctober 14, 2025 | marketbeat.comSequoia Financial Advisors LLC Acquires 1,816 Shares of Labcorp Holdings Inc. $LHOctober 13, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWhy Wall Street Is Betting Billions on Oklo's Nuclear VisionBy Jeffrey Neal Johnson | September 26, 2025AMD Could Double From Here—Thanks to Its Blockbuster OpenAI DealBy Thomas Hughes | October 7, 2025Conagra Brands High-Yield and Deep Value Are a Buy in OctoberBy Thomas Hughes | October 3, 2025Solana Beat BTC and ETH in Q3: These 3 Stocks Saw It ComingBy Dan Schmidt | September 24, 20253 Automation-Focused Stocks Flying Under the RadarBy Nathan Reiff | September 22, 2025LH, DGX, DVA, and CHE Company DescriptionsChemed NYSE:CHE$440.10 +9.18 (+2.13%) Closing price 10/17/2025 03:59 PM EasternExtended Trading$440.54 +0.45 (+0.10%) As of 10/17/2025 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Quest Diagnostics NYSE:DGX$189.71 +2.89 (+1.55%) Closing price 10/17/2025 03:59 PM EasternExtended Trading$189.51 -0.20 (-0.11%) As of 10/17/2025 05:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$125.79 +0.54 (+0.43%) Closing price 10/17/2025 03:59 PM EasternExtended Trading$126.04 +0.25 (+0.20%) As of 10/17/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Labcorp NYSE:LH$285.65 +1.95 (+0.69%) Closing price 10/17/2025 03:59 PM EasternExtended Trading$289.02 +3.37 (+1.18%) As of 10/17/2025 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom Inks OpenAI Deal: Why It's A Huge Win for AVGO Stock Institutions Are Fueling CrowdStrike’s Next Leg Higher This AI Chip Giant Could Be the Market’s Next Big Winner Microsoft & NVIDIA Unveil GB300 Supercomputer as AI Race Heats Up This Less-Hyped Tech Stock Could Be the Key to the Next AI Wave Archer Buys Rival's Patent Treasure Trove in Strategic Move Prologis Stock Surges: Why the Rally May Continue Intel's Turnaround Hits Hyperspeed With A New 52-Week High Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.